Disease | hartnup disease |
Comorbidity | C0038012|spondylitis |
Sentences | 3 |
PubMedID- 24286564 | In earlier reports, mcii for eq-5d has been found to vary considerably (0–0.69) in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis after 3 months of treatment with disease-modifying anti-rheumatic drugs, indicating that mcii is dependent on patient group (kvamme et al. |
PubMedID- 23297014 | Il-8 but not other biomarkers of endothelial damage is associated with disease activity in patients with ankylosing spondylitis without treatment with anti-tnf agents. |
PubMedID- 24447112 | Effect of tumour necrosis factor-alpha inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity. |
Page: 1